Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

139
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
139

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting the transcription factor GATA3 by the DNAzyme formulation SB012 in patients with moderately-to-severely active ulcerative colitis: a multicenter, randomized, placebo-controlled, phase 2a induction trial.

Inflammatory bowel diseases·2026
Same author

JAK inhibitors in the management of extra-intestinal manifestations in inflammatory bowel disease.

Therapeutic advances in gastroenterology·2025
Same author

Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: A comparative analysis in a European real-world cohort.

Hepatology communications·2024
Same author

Integrin αVβ6: Autoantigen and Driver of Epithelial Remodeling in Colon and Bile Ducts in Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.

Journal of Crohn's & colitis·2024
Same author

p21 Prevents the Exhaustion of CD4<sup>+</sup> T Cells Within the Antitumor Immune Response Against Colorectal Cancer.

Gastroenterology·2023
Same author

Novel Small Molecules in IBD: Current State and Future Perspectives.

Cells·2023

Related Experiment Video

Updated: Dec 22, 2025

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

9.3K

Nanoparticles in Gastrooncology.

André Jefremow1, Markus F Neurath1

  • 1Department of Internal Medicine 1, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.

Visceral Medicine
|May 2, 2020
PubMed
Summary
This summary is machine-generated.

Nanomedicine offers new hope for gastrointestinal (GI) cancers by using nanoparticles to target tumors. This approach enhances diagnosis and treatment, though challenges in nanoparticle design remain.

Keywords:
Gastrointestinal tumorsGastrooncologyNanomedicineNanoparticles

More Related Videos

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
07:54

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

8.5K
Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /T1Magnetic Resonance Imaging
07:26

Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /T1Magnetic Resonance Imaging

Published on: November 20, 2018

6.8K

Related Experiment Videos

Last Updated: Dec 22, 2025

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

9.3K
Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
07:54

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

8.5K
Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /T1Magnetic Resonance Imaging
07:26

Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /T1Magnetic Resonance Imaging

Published on: November 20, 2018

6.8K

Area of Science:

  • Oncology
  • Nanotechnology
  • Gastroenterology

Background:

  • Gastrointestinal malignancies represent a significant global health burden with high incidence and mortality rates.
  • Current treatments like surgery, chemotherapy, and radiation often fall short of achieving cancer-free survival.

Purpose of the Study:

  • To review the current status of nanomedicine in diagnosing and treating gastrointestinal cancers.
  • To highlight advancements and identify unresolved challenges in the field.

Main Methods:

  • Review of existing literature on nanomedicine applications in GI oncology.
  • Analysis of in vitro, preclinical, and clinical data on nanoparticle-based therapies.

Main Results:

  • Nanoparticles enable targeted delivery of anticancer agents directly to tumor sites.
  • Simultaneous diagnostic and therapeutic capabilities can be achieved with single nanoparticles.
  • Nanoparticles can be engineered to carry multiple therapeutic agents, enhancing treatment efficacy.

Conclusions:

  • Nanomedicine presents promising new therapeutic and diagnostic options for GI tumors.
  • Despite progress, challenges persist in designing nanoparticles with optimal characteristics.
  • Further research is needed to address current limitations and advance nanomedicine in clinical practice.